Safety of Biologics: The Risk of Infection and Malignancy With Biologic Therapy

Safety of Biologics: The Risk of Infection and Malignancy With Biologic Therapy is organized by LearnSkin.

Release date: November 11, 2020
Expiration date: November 10, 2023

Description:
Part of a 14-course series, this activity is designed to provide licensed practitioners and dermatologists with an understanding of the basic principles of managing patients with psoriasis in the 21st century. This series will provide participants with advanced understanding of current concepts in etiology, diagnosis, and management of psoriasis.

Learning Objectives
After completing this activity, participants will able to:
• Classify the common safety precaution for biologics based on class of medications.
• Analyze the data from clinical trials and registry studies.